1.Comparison of Trimethoprim Content in Compound Dihydroartemisinin Tablets Determined by Dual-wavelength Spectrophotometry and HPLC
Wenzhong XIAO ; Meiyi ZHANG ; Yanfang LIN ; Lizhi ZHAN ; Linchun FU ; Guoqiao LI
Journal of Guangzhou University of Traditional Chinese Medicine 2000;0(04):-
Objective To compare the effects of dual-wavelength spectrophotometry and HPLC on the content of trimethoprim(TMP)in Compound Dihydroartemisinin Tablets.Methods HPLC was performed in a column of C 18 with acetonitrile and 0.75% diethylamine(15∶85,adjusting pH to 2.5 by phosphoric acid)as the mobile phase and the detecting wavelength was at 271nm.The detecting wavelength was also at 271nm with reference wavelength at 366nm in dual-wavelength spectrophotomerty.Results Within 20.0~100.0 ?g/mL,TMP has a good linearity(r=0.999 94)by HPLC,and the average recovery was 100.9% with RSD being0.24%(n=5).By dual-wavelength spectrophotometry,a good linearity(r=0.999 95)of TMP was within 5.0~25.0 ?g/mL,and the average recovery was 100.0% with RSD being 0.45%(n=5).Conclusion Both dual-wavelength spectrophotometry and HPLC can be used to determine the content of TMP in Compound Dihydroartemisinin Tablets,but the former can detect the content of TMP directly without the disturbance of piperaquine phosphate and is simple,rapid and accurate.
2. Meta-analysis of the relationship between the polymorphism of ACE and TNF-α gene and the susceptibility of sarcoidosis
Journal of Chinese Physician 2020;22(1):36-42
Objective:
To evaluate the relationship between angiotensin converting enzyme (ACE) and tumor necrosis factors-α (TNF-α) gene polymorphism and sarcoidosis.
Methods:
Meta analysis was carried out by retrieving the studies published up to July 2018 to evaluate the relationship between ACE and TNF-α gene polymorphism and sarcoidosis. RevMan 5.3 and Stata 12.0 software were used to analyze the combined
3.Effects of immunotherapy on CD69 expression on NK cells at the fetomaternal interface and the relationship with the outcomes of murine fetuses and pups
Yi LIN ; Yaoying ZENG ; Shan ZENG ; Xianhui HE ; Jingfang DI ; Meiyi ZHAN ; Jiebin GUAN ; Jingxian ZHAO ; Shimin QUAN
Chinese Journal of Pathophysiology 1986;0(03):-
AIM: To examine the expression of CD69 on NK cells at the fetomaternal interface in CBA/J?DBA/2 mice as a model of recurrent spontaneous abortion (RSA), and to evaluate the effects of lymphocyte immunotherapy (LIT) on the level of CD69 expression and the relationship with the outcomes of murine fetuses and pups. METHODS: The outcomes of murine fetuses and pups were evaluated in breeding pairs of CBA/J?DBA/2, C57BL/6?DBA/2 and BALB/c?DBA/2 mice. Both preweaning growth curves and Kaplan-Meier survival graphs of pups were constructed throughout postnatal days 1 to 21. In addition, the level of CD69 expression on NK cells at the fetomaternal interface with and without LIT were determined by two-color flow cytometric analysis, stained with PE-CD69 and FITC-DX5. The subpopulation of CD16/CD32 + NK cells was also evaluated. RESULTS: Statistically significant differences were observed between CBA/J?DBA/2 mice and normal fertile controls in the median increase of maternal weight during pregnancy, the number of pups born per litter, the median neonatal weight on postnatal day 1, and the resorption rate of fetuses. The proportion of CD69 +DX5 + cells which represents activated NK cells was significantly higher in CBA/J?DBA/2 mice compared with normal fertile controls, while efficient LIT was able to dramatically decrease the expression of CD69 on NK cells at the fetomaternal interface and this was associated with the decrease of resorption rate accordingly. CONCLUSION: The fraction of CD69 +DX5 + cells seems to be functionally important in the mechanisms by which the embryos were rejected, whereas efficient LIT is capable of reducing the abortion rate via decreasing the expression of CD69 molecules on NK cells at the fetomaternal interface.
4.Effect of contralateral saphenous vein bypass in the treatment of chronic femoral vein obstruction
Junpeng CUI ; Meiyi LIN ; Baolin LIU
International Journal of Surgery 2017;44(11):742-745,封3
Objective To study the feasibility and practicability of contralateral saphenous vein bypass in the treatment of chronic femoral vein obstruction.Methods A retrospective analysis was consisted of 33 patients who received contralateral great saphenous vein bypass during the period of June 2013 to June 2017 in the Deperrtment of Biloary Vascular Surgery of Shengjing Hospital of China Medical University.All patients after operation were followed up of 2 months deadline to August 2017 by telephone or outpatient,the follow-up content including lower limb activity after resting and subjective sensation,lower limb swelling degree and so on.The measurement data was expressed by mean standard deviation ((x) ± s),paired samples t test was used for comparison among groups.Linear correlation coefficient was used to describe the difference between ankle circumference and the time to maintain anticoagulation therapy after acute thrombosis,then we explored the effect and advantages of this surgical methods.Results Compared with the preoperative index,the activated partial thromboplastin time [(21.93 ± 3.36) svs(18.11 ±2.24)s,P<0.05],the thrombus elastic map R value[(5.45 ±0.73)min vs(4.20 ± 0.39) min,P < 0.05],the D-dimer [(3 502.79 ± 4 028.02) μg/L vs (5127.76 ± ± 4722.42) μg/L,P < 0.05] and the ankle circumference [(22.23 ± 1.28) cm vs (25.38 ± 0.78) cm,P < 0.05] were improved,and the prothrombin time [(12.63 ± 1.74) s vs (12.32 ± 1.14),P >0.05] showed no difference before and after the operation (P > 0.05).With the extension of time,the effect of bypass on the treatment of lower limb edema weakened.Postoperative follow-up indicated that 33 cases of patients were unobstructed and returned to normal state,21 cases could tolerated normal physical activity and had no or mild swelling,12 cases occasional had moderate swelling while the swelling could disappear after lying down for a rest,symmetric of double lower limbs in all patients returned to acceptable degree and did not affect the clothing or appearance.Conclusion The contralateral saphenous vein bypass operation has better effect and less trauma,it can improve the lower limb edema and endogenous coagulation system of chronic obstructive iliac vein disease,and the effect is better after conservative treatment for half a year.
5.Application of transcutaneous electric nerve stimulation combined with cognitive behavior intervention in the elderly coronary disease patients with hypertension
Xin XIN ; Shuang LIN ; Meiyi MIAO ; Chunyu MU ; Ye LU
Chinese Journal of Modern Nursing 2020;26(10):1364-1367
Objective:To explore the effects of transcutaneous electric nerve stimulation (TENS) combined with cognitive behavior intervention in the elderly coronary disease patients with hypertension.Methods:From May 2017 to May 2019, we selected 90 elderly coronary disease patients with hypertension in the Second Affiliated Hospital of Harbin Medical University as subjects by convenience sampling. All of patients were divided into control group and observation group with the method of random number table, 45 cases in each group. Control group carried out cognitive behavior intervention, while observation group implemented the TENS combined with cognitive behavior intervention. We compared the angina pectoris symptom control, blood pressure control and the self-perceived burden with the Self-perceived Burden Scale (SPBS) of patients between two groups.Results:After intervention, the effective rate of angina pectoris control of observation group was higher than that of control group with a statistical difference ( P<0.05) ; the diastolic pressure and systolic pressure of observation group were lower than those of control group with statistical differences ( P<0.05) ; the score of SPBS of patients in control group was higher than that in control group also with a statistical difference ( P<0.001) . Conclusions:TENS combined with cognitive behavior intervention for elderly coronary disease patients with hypertension contributes to angina pectoris symptom control and reducing the blood pressure as well as self-perceived burden.
6.Progress in the development of mRNA vaccine and its delivery systems for anti-tumor immunotherapy
Meiyi XIN ; Yuhong LIN ; Kai ZHAO
China Oncology 2024;34(5):509-516
Due to the drawbacks of low specificity and high risk of side effects of traditional anti-tumor treatments in clinical practice,novel anti-tumor immunotherapy has received attention and has been gradually applied.Tumor immunotherapy is to enhance the anti-tumor immune response by regulating the body's immune system in order to achieve control and killing of tumors.Tumor immunotherapies include immune checkpoint blockade therapy,over-the-counter cellular immunotherapy and tumor vaccines.Among them,the tumor vaccine stimulates the immune system to produce specific immune cells or antibodies by delivering tumor cell-specific antigens thereby eliminating the tumor cells for the purpose of treating the tumor.In recent years,The field of mRNA vaccines is developing rapidly,and the required mRNA in the synthesis and preparation of the process has been developed and matured,laying a good foundation for the research of tumor mRNA vaccine.Because of the fact that mRNA is easily degraded and cannot enter the cell autonomously,this vaccine requires a suitable delivery vehicle to be successfully taken up by the cell to be effective.Therefore,the development of mRNA vaccine delivery systems has become critical for their better utilization,which is also an important part of whether mRNA vaccines can be developed and utilized for the clinical stage in the field of tumor therapy.This paper briefly introduced the immunotherapeutic methods for tumors,types of tumor vaccines and the mechanism of action and preparation methods of tumor mRNA vaccines,reviewed the research progress and related applications of mRNA vaccines and their common delivery systems in immunotherapy for tumor treatment,and summarized the tumor mRNA vaccines that entered into the phase of clinical trials with the aim of providing assistance for the research of mRNA vaccines for tumors in the future.